A PCT test measures procalcitonin in blood, a protein that climbs quickly during serious bacterial infection and usually stays low in viral illness. Hospitals use it to judge how likely a bacterial infection is, to help gauge sepsis risk, and to support decisions about how long a treatment course continues, often alongside C-Reactive Protein.
A PCT test measures procalcitonin, the precursor of the hormone calcitonin, in a sample of blood. In a healthy adult, the C cells of the thyroid make small amounts and convert almost all of it, so the amount left circulating sits close to the limit of what laboratory assays can detect.
That changes during a systemic bacterial infection. Tissue throughout the body, including liver, lung, kidney, gut, fat and muscle, switches on the gene that produces procalcitonin and releases it unprocessed into the bloodstream. Components of bacterial cell walls and the cytokine signals that follow them drive this release, and the rise can be measured within hours rather than days 1.
Two features make the molecule useful at the bedside. The first is where it comes from. Because the release during infection is widespread rather than thyroid driven, the level tends to reflect how much of the body is caught up in the response rather than the state of one organ. The second is what holds it back. Signals generated during viral infection blunt that same release, which is part of why viral illness generally produces a smaller rise than a bacterial infection of similar severity 1.
Procalcitonin released this way does not behave like the hormone it would otherwise become, and it does not disturb calcium handling. A raised result is a signal about the immune response, not a sign of a thyroid or calcium problem.
One practical note on units. Most laboratories report procalcitonin in ng/mL, which is numerically identical to µg/L, so 0.5 ng/mL and 0.5 µg/L describe the same result.
Clinicians order it because the everyday signs of infection are honest but vague. Fever, a fast heart rate, a raised white blood cell count and feeling unwell all appear in viral illness, bacterial illness, inflammation after surgery and several conditions that have nothing to do with microbes at all. A marker that leans more specifically toward systemic bacterial infection adds a piece of information the vital signs cannot supply on their own.
In practice the question takes three forms. The first is likelihood. How probable is it that a bacterial process is driving this illness, particularly when a chest film is ambiguous or cultures will take time. The second is severity and direction. Because levels move quickly, a repeat measurement after some hours shows whether the systemic response is building or settling. The third is duration. A falling marker supports the judgement that the body is winning, and research suggests that using procalcitonin to guide those judgements may help shorten the number of days antibiotics are given in some hospital settings 1.
It is worth being clear about what the test is not. It is an acute care marker, used when someone is unwell now, in an emergency department, on a ward or in intensive care. It is not a screening test for healthy people, and it is not read as a single verdict. Studies suggest it carries moderate accuracy for identifying sepsis in acutely ill adults, enough to inform a decision but not enough to confirm or exclude anything alone 2.
In healthy adults, procalcitonin is typically below about 0.05 ng/mL, close to the detection limit of most assays. Above that, hospitals use interpretive bands rather than a simple normal or abnormal split, because the number is read as a probability rather than a yes or no.
| Procalcitonin (ng/mL, same as µg/L) | How laboratories and clinicians commonly regard it |
|---|---|
| Below 0.1 | Systemic bacterial infection unlikely in most adult settings |
| 0.1 to 0.25 | Bacterial infection less likely, the clinical picture leads the decision |
| 0.25 to 0.5 | Bacterial infection possible, read with symptoms, examination and other tests |
| 0.5 to 2 | Bacterial infection more likely, a systemic response may be under way |
| 2 to 10 | Marked systemic response, commonly prompts urgent clinical review |
| Above 10 | Very marked systemic response, typically seen in severe illness |
These are typical interpretive bands used in hospital pathways, not diagnostic cut-offs. Reference ranges and thresholds vary by laboratory, assay, age and clinical setting, and newborns in their first days of life follow entirely separate thresholds because levels rise normally after birth. Read the range printed on your own report rather than a figure from elsewhere.
Two other points shape interpretation. Different assays do not always produce identical numbers, so a trend is most reliable when the samples run on the same platform. And the band a result falls into matters less than the direction it is travelling, because a value of 0.8 ng/mL on the way down tells a different story from the same value on the way up.
A raised procalcitonin reflects a widespread inflammatory release of the kind systemic bacterial infection typically drives, and higher levels tend to track with more extensive involvement of the body 1. That is the observation. The meaning is narrower than it first looks.
What the number genuinely supports is a shift in probability. A result of 2 ng/mL in someone with fever and low blood pressure makes a bacterial systemic process more plausible than the same presentation with an undetectable result, and higher values are associated with a greater likelihood that the response has become systemic 1. What the number cannot do is name an organism, locate the source, or separate infection from the other severe physiological stresses that provoke the same release.
There is also a timing trap. A sample drawn very early, within the first hours of an illness, can sit low simply because the rise has not happened yet. That is one reason repeat testing is common when suspicion stays high despite a reassuring first result.
The next step after a raised value is always clinical rather than numerical. A clinician looks at breathing rate, blood pressure, mental state, oxygen levels, examination findings and other bloodwork, and decides what investigation or care the person needs. Treatment decisions belong to a licensed provider. If you are holding a raised result and feel unwell, that is worth discussing with a clinician promptly rather than waiting for a routine appointment.
A low or undetectable procalcitonin suggests that a systemic bacterial response is less likely at the moment the blood was drawn. In an unwell person it often supports a viral illness, a localised infection that has not provoked a body wide response, or an inflammatory process with a different driver.
That word moment carries weight. Low does not mean nothing is wrong. Infections confined to one compartment, such as some urinary, skin, joint or abscess infections, can produce modest rises or none at all, because the systemic release depends on how much of the body is engaged. Very early sampling can also catch a level before it has climbed, and in people who are immunosuppressed the response may be muted.
So the correct reading of a low result is a shift in probability, not a clearance certificate. Clinicians treat it as one input that makes a systemic bacterial cause less likely while the examination, imaging, cultures and the person's trajectory continue to carry the decision. A low value in someone who looks genuinely unwell is a prompt to keep looking, not a reason to stop.
The reverse mistake also matters. A reassuring marker never cancels worrying signs. Confusion, fast breathing, low blood pressure or rapid deterioration call for emergency care regardless of what any number says.
C-Reactive Protein is a protein made by the liver that rises with inflammation of almost any cause, infectious or not. A typical lab reference range is 0 to 3 mg/L, and FitScript's optimal range is 0 to 1 mg/L. Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs, and standard reference ranges vary by lab, age and sex.
What CRP measures, how it is tested and how to read a result all sit on the dedicated C-Reactive Protein guide, which is the right place to go for the full picture. For this page, one contrast is enough. CRP is the broader and slower signal, while procalcitonin is tuned more narrowly toward systemic bacterial infection and moves faster in both directions.
They answer different questions, which is why hospitals frequently run both. The table below sets out the practical differences.
| Feature | Procalcitonin | C-Reactive Protein |
|---|---|---|
| Main source during illness | Many tissues release it during a systemic response | Liver, driven by inflammatory signalling |
| Typical trigger | Bacterial components and the cytokines that follow | Inflammation of almost any cause, including injury, autoimmune activity and surgery |
| Speed of rise | Begins within hours of a systemic insult 1 | Slower, tends to lag behind |
| Behaviour once the source is controlled | Falls comparatively quickly 1 | Falls more gradually |
| Response in viral illness | Usually blunted 1 | Often rises, sometimes substantially |
| Everyday clinical use | Acute decisions about systemic bacterial infection and treatment duration | Acute inflammation, plus long term inflammatory context when measured as high sensitivity CRP |
| Presence in wellness panels | Rare | Common |
The practical consequence is that CRP tells you inflammation is present and roughly how much, while procalcitonin leans toward telling you what kind of insult is driving it. Neither replaces the other. A high CRP with a flat procalcitonin suggests inflammation without a strong systemic bacterial signature, while both climbing together points more firmly toward a body wide infectious response. Clinicians read the pair alongside the examination rather than ranking one above the other.
It shifts the odds usefully, but it does not settle the question. Research suggests that procalcitonin alone cannot reliably separate bacterial from viral community acquired pneumonia, because the two distributions overlap enough that no single threshold cleanly divides them 3.
That finding is worth sitting with, because it is often misquoted in both directions. The marker is not useless for this question. Viral infection does tend to produce lower values than bacterial infection of similar severity, which is why very low results genuinely make a bacterial cause less likely. What the overlap means is that a mid range value belongs to plenty of people in both groups, so a number near a cut-off cannot carry a decision by itself 3.
Several things blur the line further. Viral and bacterial infections often coexist, particularly in the chest. Severity influences the level independently of the organism, so a severe viral illness can produce a higher value than a mild bacterial one. And timing again matters, since a sample taken early in the course may understate what is building.
The workable summary is that procalcitonin is one weighted input into a probability, read alongside symptoms, examination, imaging, oxygen levels and cultures. A clinician combines those into a judgement, and any decision about what follows belongs to a licensed provider.
It helps identify a systemic infectious response early, which is the window where recognition matters most. Sepsis is the body's dysregulated response to infection, and the difficulty is that its early appearance overlaps with many non-infectious causes of severe inflammation, such as major surgery, pancreatitis or trauma.
The measured performance is consistent across several reviews, and it is consistently moderate. Studies suggest procalcitonin is a helpful marker for the early recognition of sepsis in critically ill adults while falling short of the accuracy needed to confirm or exclude it alone 2. Studies indicate that procalcitonin and C-Reactive Protein both carry diagnostic value for sepsis, with neither sufficient as a standalone test 4. A more recent review likewise suggests that the two markers perform broadly comparably for sepsis, with the balance between them shifting according to the threshold and the setting applied 5. In emergency department adults specifically, research suggests that measured accuracy depends heavily on the cut-off chosen, which is part of why different hospitals use different thresholds 6.
Taken together, that is a marker that earns its place in the workup without ever becoming the workup. Scores built from vital signs, lactate, cultures, imaging and the clinician's assessment carry the diagnosis. Procalcitonin adds weight to one side of the question and gives a value that can be repeated in a few hours to see which way the illness is moving.
None of this changes the first rule. Suspected sepsis is a time critical emergency, and the signs named at the top of this page need emergency care immediately rather than a blood test first.
It supplies an objective trend that can support stopping sooner. Once a systemic bacterial infection comes under control, procalcitonin falls comparatively quickly, and that fall can be seen before many other markers have moved 1. A number that drops steadily over successive days is a measurable sign that the systemic response is resolving.
This is why procalcitonin guided decision making entered hospital stewardship work at all. Research suggests that procalcitonin guided algorithms may help reduce the number of days antibiotics are given in some hospital settings, which is the practical goal of stewardship 1. The marker is used as a prompt to reassess, not as an instruction.
Several limits are built into that use. The algorithms are designed for particular populations and particular infections, so they do not transfer freely between settings. A falling marker in someone who is still clinically unwell does not override the clinical picture. And a single value says far less than a sequence of values from the same laboratory.
The decision itself never belongs to the number. Treatment decisions belong to a licensed provider, who weighs the trend against the diagnosis, the source, the cultures and how the person is actually doing. Nothing on this page should be used to start, change, shorten or stop any course of care.
Plenty, which is the single most important caveat when reading a result. The same widespread inflammatory release that bacterial infection triggers can be set off by severe physiological stress of other kinds, and research suggests that procalcitonin rises after major surgery, severe trauma, burns and cardiac arrest, which is why timing relative to those events matters so much 1.
Other influences change the picture in different ways.
The practical rule that follows is simple. A procalcitonin result is only interpretable alongside what happened to the person in the preceding days. A value of 3 ng/mL on the first morning after major abdominal surgery and the same value in someone who has been unwell at home for three days carry very different weight, and a clinician who knows the context is the one who can tell them apart.
It is a standard venous blood draw, usually from the arm, processed as serum or plasma on an automated immunoassay. No fasting is needed, no preparation is required, and the sample is often collected at the same time as other urgent bloodwork, so it rarely means an extra needle.
Turnaround depends on the laboratory and the platform, so the realistic answer is that it varies and the care team will know the local timing. Some settings run point of care versions that return a result faster, which matters most when a decision cannot wait. What stays constant is that assays differ, so comparing a value from one platform with a value from another can mislead. Where possible, serial samples are run by the same laboratory.
Repeat testing is normal rather than exceptional. Because the level moves within hours, a second or third measurement over a day or two shows the direction of travel, and direction frequently carries more information than any single figure 1. A clinician decides the interval based on how the person is doing.
One limitation is worth naming. This test is ordered when there is an active clinical question. It is not something to arrange independently out of curiosity, and a result produced without the surrounding clinical context is difficult to interpret and easy to misread in either direction.
Several, because no inflammatory marker is informative in isolation. A clinician assessing possible infection usually reads procalcitonin inside a panel rather than beside it.
The common thread is that each marker answers a different question. Procalcitonin leans toward whether the response looks bacterial, lactate toward how hard the body is struggling, cultures toward what is responsible, and the blood count toward how the immune system is reacting overall.
Generally not, and the reason is structural rather than a judgement on the test. Procalcitonin answers a question asked about someone who is acutely unwell right now. In a person who feels well, the expected result is a value near the detection limit, which repeats month after month and says nothing useful about long term health.
The marker that does carry long term information about inflammation is high sensitivity C-Reactive Protein, which reflects the low grade inflammatory tone that tracks with metabolic and cardiovascular health over years rather than hours. That is the inflammation marker that belongs in an optimization panel, read alongside metabolic markers, lipids, body composition and the rest of the picture. FitScript's membership tests 150+ biomarkers per year and includes inflammatory markers of that kind, with Atlas, the AI health advisor, reading each result in the context of the rest of the panel rather than in isolation.
Understanding procalcitonin still has value outside a wellness panel. If you or a family member ends up in hospital with a fever and someone mentions a PCT level, knowing what the number is doing, and what it cannot tell anyone, makes the conversation with the care team a far better one. The purpose of knowing a marker is not always to track it.
Any result outside the range printed on your report is worth discussing with a clinician promptly, and some situations should not wait for a discussion at all.
Fever with confusion, fast breathing, low blood pressure, a very fast heart rate, mottled or discoloured skin, reduced urine output, or a sudden sense of getting much worse all need emergency care immediately, call 911. Those signs are acted on at once, and no blood marker should ever be the reason to delay.
Short of that, these situations deserve same day or prompt contact. A raised procalcitonin alongside ongoing fever or feeling unwell. A level that is climbing rather than settling across repeat samples. A persistent raised value with no clear explanation after a recognised cause such as surgery or trauma has passed. Illness that is not improving in the expected way, even when the markers look reassuring.
Two things make these conversations more productive. Bring the actual numbers and their dates, because the trend is often the most informative part. And bring the context, including recent surgery, injury, kidney problems or a weakened immune system, because all of those change how a value should be read.
This page is health education and not medical advice. Discuss your own results and any question about care with a clinician or licensed provider who can review your full history.
For related reading, FitScript's guide to wbc explains what the white blood cell count measures and why it is read alongside inflammatory markers when infection is suspected.
PCT stands for procalcitonin, the precursor molecule of the hormone calcitonin. On a hospital report it is usually given in ng/mL, which is numerically the same as µg/L. It is ordered to help judge how likely a systemic bacterial infection is in someone who is unwell.
In healthy adults, procalcitonin usually sits below about 0.05 ng/mL, close to the detection limit of most assays. Hospital pathways commonly regard values below 0.1 ng/mL as making a systemic bacterial infection unlikely, while values above 0.5 ng/mL raise more concern. Thresholds differ by laboratory, assay and age, so read the range printed on your own report.
A high result suggests the body is mounting the kind of widespread response that systemic bacterial infection typically drives, and higher values generally go with more of the body being involved. It is not a diagnosis on its own, because surgery, trauma, burns and other severe stress can raise it too. A clinician reads it with your symptoms, examination and other tests before deciding anything.
Yes. Major surgery, severe trauma, burns, cardiac arrest, prolonged shock, some neuroendocrine tumours and reduced kidney clearance can all lift the level. Newborns also show a normal rise in their first days of life. That is why the timing of the sample and the person's recent history matter as much as the number itself.
Both rise with inflammation, but procalcitonin leans more specifically toward systemic bacterial infection while CRP rises with inflammation of almost any cause. Procalcitonin also moves faster in both directions, which makes repeat sampling over hours useful. CRP is the one more often included in routine wellness bloodwork, usually as high sensitivity CRP.
It can begin climbing within a few hours of a systemic bacterial insult and typically peaks within the first day. It also falls comparatively quickly once the source is under control, which is why a falling trend is often more informative than any single value. Repeat samples are best run by the same laboratory so the numbers can be compared fairly.
Usually not. It is an acute-care marker that answers a question asked about someone who is unwell right now, not a long-term optimization marker. In a healthy person the result is expected to sit near the detection limit. For tracking low grade inflammation over time, high sensitivity CRP is the more common choice.
Fever with confusion, fast breathing, low blood pressure, a very fast heart rate, mottled skin, reduced urine output or a sudden sense of getting much worse all need emergency care, call 911. Those signs are acted on immediately and no blood marker should delay that. Any abnormal result you already hold is worth discussing with a clinician promptly.